More than $15 billion of capital was accessed by Indiana’s life sciences companies in 2021. BioCrossroads today issued their annual report, Indiana Life Sciences Capital 2021, which provides details on the funding events throughout the year, including $6.5 million in Small Business Innovation Research (SBIR) awards to 17 companies, a record $433.5 million in Venture Capital invested in 39 companies, $508 million accessed through public markets by four companies, $13.7 billion+ spent to acquire innovation representing 13 transactions, and $521 million in capital to establish, expand, or upgrade facilities by 23 companies.
BioCrossroads advances Indiana’s signature strengths in the life sciences by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start ups; building new enterprises; and educating through conferences, reports and market development knowledge.
NEWSLETTER SIGN UP
1210 Waterway Boulevard,
Indianapolis, IN 46202